Cargando…
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury
BACKGROUND: Immunomodulatory therapies have been identified as interventions for secondary injury after traumatic brain injury (TBI). The cannabinoid receptor type-2 (CB(2)R) is proposed to play an important, endogenous role in regulating inflammation. The effects of CB(2)R stimulation, blockade, an...
Autores principales: | Amenta, Peter S, Jallo, Jack I, Tuma, Ronald F, Hooper, D. Craig, Elliott, Melanie B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248435/ https://www.ncbi.nlm.nih.gov/pubmed/25416141 http://dx.doi.org/10.1186/s12974-014-0191-6 |
Ejemplares similares
-
Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion
por: Elliott, Melanie B, et al.
Publicado: (2017) -
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity
por: Mehrpouya-Bahrami, Pegah, et al.
Publicado: (2017) -
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020) -
Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity
por: Hinden, Liad, et al.
Publicado: (2023) -
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
por: Long, Jonathan Z., et al.
Publicado: (2008)